Startup Atara Bio raises $38.5 million to push first 2 drugs into clinical trials

Loaded with two former Amgen Inc. drugs, $38.5 million in fresh cash and a unique structure — and with a sentimental nod to its CEO’s late mother — year-old Atara Biotherapeutics Inc...